Watch the Demo
Learn how to use the Strep A 2 test by watching this product demonstration.
Global Point of Care
ID NOW™
Confidence that Cares.
Rapid, Molecular Results at the Point of Care
The ID NOW rapid molecular platform uniquely combines speed, accuracy, and ease of use to get confident answers to relevant diagnostic questions - helping improve point of care testing for a more efficient patient care experience.
For in vitro Diagnostic Use.
Confidence that Cares.
Rapid, Molecular Results at the Point of Care
The ID NOW rapid molecular platform uniquely combines speed, accuracy, and ease of use to get confident answers to relevant diagnostic questions - helping improve point of care testing for a more efficient patient care experience.
For in vitro Diagnostic Use.
Benefits
Provide Better Care for Patients.
- Helps ensure more patients receive specific Flu, Covid, or Strep treatment
- Supports reduction of unnecessary antibiotics complications and follow-ups
- Improve Efficiency
- Provide results during the patient interaction to shorten visits and improve workflows
- Helps reduce need for confirmatory testing
- Reduce manual work and potential for transcription errors with EMR/Middleware connectivity
- Increase Patient and Clinician Satisfaction
- Supports clinician confidence and reduced patient wait time
- Support Diagnostic Stewardship: Providing the Right Test to the Right Patients
- Gives clinicians flexibility to test only for relevant diseases based on seasonality, patient risk profile, etc.
SIMPLE AND SECURE RESULTS REPORTING
Track, consolidate and report ID NOW™ test results from multiple decentralized instruments and locations using RALS™.
Illuminating Insights: Rapid Molecular Testing for Respiratory Disease
Rapid molecular testing is an important tool in the fight against respiratory infectious disease. The ID NOW™ platform can lead to faster diagnosis and better overall patient care.
ID NOW™ is significantly faster than other molecular methods and more accurate than conventional rapid tests.
Helpful Documents
PRODUCT DOCUMENTS
PRODUCT CODE
| ID NOW™ System | Code |
|---|---|
| ID NOW™ Instrument | NAT-024 |
| ID NOW™ COVID-19 2.0 Control Kit | 192-080 |
| ID NOW™ Influenza A & B 2 24 Test Kit | 427-000 |
| ID NOW™ Influenza A & B Control Swab Kit | 425-080 |
| ID NOW™ Strep A 2 24 Test Kit | 734-000 |
| ID NOW™ Strep A 2 Control Swab Kit | 734-080 |
| ID NOW™ RSV 24 Test Kit | 435-000 |
| ID NOW™ RSV Control Swab Kit | 435-080 |
| ID NOW™ Barcode Scanner | L22XWU1200 |
| Universal Printer | IDNOWPRINT |
Videos
Watch the Technology Video
Learn how Abbott utilizes unique isothermal nucleic acid amplification technology.
View References
- Bonner, A.B. et al. (2003) Impact of the Rapid Diagnosis of Influenza on Physician Decision-Making and Patient Management in the Pediatric Emergency Department: Results of a Randomized, Prospective, Controlled Trial. Pediatrics Vol. 112 No. 2.